We analysed whether the level of human epidermal growth factor receptor-2 (HER-2) amplification significantly influenced either pathological complete response (pCR) or recurrence-free survival (RFS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback